Seidelmann Scott Peter's Form 4 filing
Omnicell, Inc. (OMCL) · filed Dec 16, 2021
- Accession no.
- 0001179110-21-011069
- Filed
- Dec 16, 2021
- Trade date
- Dec 15-16, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $641.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Seidelmann Scott PeterCIK 0001736895 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | Common Stock | FTax withholdingDisposed | −3,129 | $0.00 | $0 | 37,260 | Direct | |
| Dec 16, 2021 | Common Stock | SSaleDisposed | −939 | $176.00 | −$165,264 | 36,321 | Direct | |
| Dec 16, 2021 | Common Stock | SSaleDisposed | −1,689 | $176.69 | −$298,429.41 | 34,632 | Direct | |
| Dec 16, 2021 | Common Stock | SSaleDisposed | −550 | $177.59 | −$97,674.5 | 34,082 | Direct | |
| Dec 16, 2021 | Common Stock | SSaleDisposed | −450 | $178.69 | −$80,410.5 | 33,632 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.